Pocket Guide to Diagnosis & Treatment of Cardiovascular Implantable Electronic Device (CIED) Infections
|
|
- Colin Boyd
- 5 years ago
- Views:
Transcription
1 Pocket Guide to Diagsis & Treatment of Cardiovascular Implantable Electronic Device (CIED) Infections Draft Version : November 208 DEFINITION Pocket infection, if all 4 criteria are fulfilled: Investigation/sign Local signs of infection and/ microbiology (at least one of them) Fever rigs Blood cultures (2-3 sets) Criteria Local signs of inflammation Purulent wound secretion sinus tract abscess Wound dehiscence implant on view (generat subcutaneous leads) Positive culture 3 from pocket tissue explanted CIED Absent Negative TEE No vegetations on leads 2 valves Erythema, swelling, warmth, pain tenderness 2 Fibrous strands visible of older leads seen in TEE may represent aseptic thrombus, especially if blood cultures are negative (without antimicrobial therapy) 3 F highly virulent ganisms (e.g. S. aureus, E. coli) one positive culture needed, f low-virulent ganisms (e.g. S. epidermidis, C. acnes) 2 me positive cultures are needed to confirm infection Systemic CIED infection, if criterion is fulfilled: Device-associated endocarditis (intraveus leads) Pocket infection with positive blood cultures Positive TEE (with lead valve vegetation) with positive blood cultures Positive blood cultures with gram-positive bacteria Candida spp. at two different occasions without evidence of infectious focus ptal of entry (e.g. intravascular catheter) Infective endocarditis defined by modified Duke criteria Device-associated mediastinitis pericarditis (epicardial leads) F individual recommendations contact our Consultation Ptal at: cp.pro-implant-foundation.g Copyright: PRO-IMPLANT Foundation (N. Renz, A. Trampuz) and Deutsches Herzzentrum Berlin (F. Schönrath, Ch. Starck). The Pocket Guide follows international recommendations. The Foundation cant be held responsible f any treatment failures antibiotic side effects. The latest version of the Pocket Guide is available at:
2 Intraoperative diagstics including pocket swab, tissue culture, +/- lead tip culture and device sonication. Consider molecular diagstisc in culture-negative cases. If lead extraction is too risky, consider isolated generat exchange with consecutive lifelong antimicrobial suppression. MANAGEMENT ALGORITHM POCKET INFECTION Local signs of infection Fever/rigs? Blood cultures positive current antibiotic treatment? TEE positive? Pocket infection confirmed Assess f systemic infection Superficial (erythema, stitch abscess) Deep (dehiscence, draining pus, deep abscess, pocket discomft) Within 30 days of implantation? Early postimplantation inflammation / infection Remove entire CIED and antimicrobial treatment Antimicrobial treatment with/without debridement and retention of CIED Clinical response? Close follow-up observation
3 Suspected systemic CIEDinfection Fever/rigs (unexplained) Unexplained bacteremia Evidence of distant seeding MANAGEMENT ALGORITHM SYSTEMIC CIED INFECTION Blood cultures ( 2 sets) TEE Assess f pocket infection TEE positive? Blood cultures positive? If pretreated: stopp Repeat blood cultures and follow-up closely Staphylococcus aureus Coagulase-negative staphylococci Cutibacterium spp. Candida spp. Streptococcus spp. (viridans group, betahemolytic) Enterococcus spp. Systemic CIED infection confirmed 2 cultures positive and/ other source excluded? Gram-negative bacteria Streptococcus pneumoniae Remove entire CIED 2 Treat with antimicrobials accding to endocarditis guidelines Collect surveillance blood cultures (after h) If persistent indication f CIED see Treatment algithm f CIED infections Treat bloodstream infection Closely follow-up after discontinuation of e.g. hematogeus seeding of mitral atic valve, spondylodiscitis, joints, liver, and spleen, lungs 2 Intraoperative diagstics, including pocket swab, tissue culture, lead tip culture, sonication of the device
4 SURGICAL PROCEDURES FOR CIED INFECTIONS Pocket infection d = days week 5 weeks Debridement & retention 6 weeks Debridement & removal 4 d 0 d -2 weeks One-stage exchange (contralateral side) 4 d 0 d -2 weeks Two-stage exchange (ipsilateral side) 4 d 0 d 4 weeks 4 weeks Systemic infection 4-6 weeks (endocarditis treatment) Debridement & removal 2-6 weeks individual* 2-4 weeks Two stage exchange 6-8 weeks 2 * Interval individual, as follows: if valve lead vegetation visible: >72 h after negative blood cultures following device removal If valve vegetation: >4 d after negative blood cultures following device removal Duration of antimicrobial treatment: TEE negative: S. aureus 2-4 weeks, other pathogens 2 weeks; TEE positive: valve vegetation: 4-6 weeks f S. aureus, enterococci, n-hacek gram-negative bacteria; 4 weeks f streptococci (2 weeks in combination with gentamicin in high susceptibility to penicillin), HACEK; lead vegetation and hematogeus seeding: 6 weeks, uncomplicated lead vegetation: 2-4 weeks 2 At least 6 weeks (4 weeks after reimplantation) analogous to prosthetic valve endocarditis: if valve vegetation present, early switch after 2-4 weeks i.v. to al treatment possible; in persistant bacteremia after removal, treat accding to endocarditis guidelines Debridement Explantation of device Exchange of device Reimplantation of device i.v. al with biofilm activity al without biofilm activity
5 No surgery 2 w eeks TREATMENT ALGORITHM FOR CIED INFECTIONS Pocket infection Early superficial infection (<30 days)? Debridement & retention of device 6 weeks (biofilmactive) One-stage exchange of device (contralatera l side) 2 weeks CIED-dependency? Two-stage exchange (ipsilateral side) reimplantation as soon as soft tissue is cured 4 weeks after reimplantaion (biofilm-active) Débridement & removal 2 weeks f pocket infections Endocarditis treatment (NVE) f systemic infection Systemic CIED infection Remove entire CIED CIED-dependency? Valve vegetation BC, blood cultures, TEE transesophageal echocardiography, both examination befe removal of CIED TEE+, BC + TEE -, BC + Reimplantation once BC after removal are negative f > 4 days Endocarditis treatment (as PVE 4 weeks after reimplantation, in total 6 weeks) Lead vegetation Reimplantation once BC after removal are negative f > 3 days Endocarditis treatment (as PVE after reimplantation) 2-4 weeks (S. aureus 4 weeks)
6 ANTIMICROBIAL TREATMENT Empirical intraveus treatment Ampicillin/sulbactam 3-4x3g amoxicillin/clavulanic acid 3-4x2.2g (higher dose, if systemic infection) + vancomycin 2x5mg/kg daptomycin x0mg/kg if patient septic polymicrobial infection possible: add gentamicin x240mg i.v. (adapt to body weight) if patient is allergic to penicillin: cefazolin 4x2 ( meropenem 3x2g, if anaphylaxis) if fungal infection suspected: add caspofungin x70mg Pocket infections Intraveus treatment Oral treatment ( device in situ) Oral treatment (with device in situ) Staphylococcus spp. Oxacillin-susceptible Anaphylactic reaction to penicillins methicillin-resistant Streptococcus spp. Penicillin-susceptible Anaphylactic reaction to penicillin penicillin-resistant Flucloxacillin 4x2g Cefazolin 3x2g Vancomycin 2x5mg/kg Daptomycin x 6-8mg/kg Penicillin G 4x5 Mio E Ceftriaxon x2g Vancomycin 2x5mg/kg Daptomycin x 6-8mg/kg Cotrimoxazol 2x960mg Clindamycin 3x600mg Doxycyclin 2x00mg Amoxicillin/clavulanic acid 3xg Amoxicillin 3xg Clindamycin 3x600mg Levofloxacin 2x500mg Rifampin 2x450mg Levofloxacin 2x500mg Cotrimoxazol 3x960mg Doxycyclin 2x00mg Amoxicillin 3xg Clindamycin 3x600mg Levofloxacin 2x500mg Enterococcus spp. Penicillin- and gentamicin (HL)- susceptible Amoxicillin 4x2g 3 ( gentamicin x3 mg/kg, if device in situ) Amoxicillin 3xg Linezolid 2x600mg Amoxicillin 3xg Linezolid 2x600mg Anaphylactic reaction to penicillins penicillin-resistant Vancomycin 2x5mg/kg Daptomycin x0mg/kg ( gentamicin x3 mg/kg, if device in situ) Enterobacteriaceae Anaphylactic reaction to penicillin/cephalosp ins Ceftriaxon x2g Piperacillin/tazobactam 3x4.5g Ciprofloxacin 2-3x400mg meropenem 3xg Cotrimoxazol 2x960mg Ciprofloxacin 2x750mg Ciprofloxacin 2x750mg (if resistant to ciprofloxacin, consider long-term suppression)
7 Systemic CIED infections Staphylococcus spp. Oxacillin-susceptible Anaphylactic reaction to penicillins methicillinresistant Intraveus treatment after device removal (befe reimplantation) Flucloxacillin 6x2g Cefazolin 3x2g Vancomycin 2 2x5mg/kg Daptomycin x 8-0mg/kg Intraveus treatment after reimplantation Add Rifampin 2x450mg p.o. to regimen in the left column Streptococcus spp. Penicillin-susceptible Anaphylactic reaction to penicillins penicillinresistant Enterococcus spp. Penicillin- and gentamicin (HL)-susceptible Penicillin- suscpetible and gentamicin (HL)-resistant (only E. faecalis) Anaphylactic reaction to penicillins penicillinresistant enterococci Enterobacteriaceae Penicillin G 4x5 Mio E Amoxicillin 6x2g Ceftriaxon x2g Vancomycin 2 2x5mg/kg Daptomycin x 8-0mg/kg Amoxicillin 6x2g 3 Gentamicin 2 x3mg/kg Amoxicillin 6x2g 3 Ceftriaxon 2x2g Vancomycin 2 2x5mg/kg Daptomycin x0mg/kg Gentamicin 2 x3mg/kg Fosfomycin 3x5g Ceftriaxon x2g Gentamicin 2 x3mg/kg Add Gentamicin 2 x 3mg/kg to regimen in the left column Amoxicillin 6x2g 3 Gentamicin 2 x3mg/kg Amoxicillin 6x2g 3 Ceftriaxon 2x2g Vancomycin 2 2x5mg/kg Daptomycin x0mg/kg Gentamicin 2 x3mg/kg Fosfomycin 3x5g Replace gentamicin with Ciprofloxacin 2x750mg p.o. Anaphylactic reaction to penicillins/cephalospins Candida spp. Ciprofloxacin 2-3x400mg meropenem 3xg Amphotericin B (liposomal) x 3-5mg/kg Caspofungin x50 mg Anidulafungin x200 mg to regimen in the left column Fluconazol x mg p.o. (consider suppression f year) In MRSA accding to MIC f vancomycin: if 0.5mg/L: vancomycin, if mg/l: daptomycin 2 Adjustment accding to through level: gentamicin: target < mg/l; vancomycin: target 5-20mg/l) 3 ampicillin 6x2g i.v.
8 MANAGEMENT OF BACTEREMIA IN CIED-CARRIERS (modified after DeSimone et al. Heart Rhythm 206) Positive BC in patient with CIED (without signs of pocket inflammation) Gram-negative rods Gram-positive cocci Treat primary source (routine TEE is t needed) No routine follow-up BC (unless suspect of infection relapse) other CoNS, enterococci S. aureus - + TEE Remove CIED + TEE - Treat primary source/ bacteremia (2-4weeks) Surveillance BC 2-4 weeks after stopping No alternative source Positive BC >72h Device revision <3 months Positive PET/CT Relapse of bacteremia? Remove CIED Accuracy of PET/CT f pocket infection: sensitivity 96%, specificity 97%; f systemic infection: sensitivity 76%, specificity 83% (Mahmood M., J Nucl Cardiol 207) BC, blood cultures, TEE, transthacic echocardiography, CoNS, coagulase-negative staphylococci
Pocket Guide to Diagnosis & Treatment of Ventricular Assist Device (VAD) Infections
Pocket Guide to Diagnosis & Treatment of Ventricular Assist Device (VAD) Infections CLASSIFICATION OF VAD-INFECTIONS Draft Version 1: 1 November 2018 from Hannan M et al. Journal of Heart and Lung Transplantation,
More informationPocket Guide to Diagnosis & Treatment of Vascular Graft Infections (VGI)
Pocket Guide to Diagsis & Treatment of Vascular Graft Infections (VGI) DEFINITION Investigation /sign Local signs of infection Histopathology Microbiology Definitive Criteria Purulent wound secretion sinus
More informationWho should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3
Neurosurgical infections (adult only) Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationInteractive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe
Interactive session: adapting to antibiogram Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe Case 1 63 y old woman Dx: urosepsis? After 2 d: intermediate result: Gram-negative bacilli Empiric antibiotic
More informationManagement of Native Valve
Management of Native Valve Infective Endocarditis 2005 AHA 2015 Baddour LM, et al. Circulation. 2015;132(15):1435-86 2009 ESC 2015 Habib G, et al. Eur Heart J. 2015;36(44):3075-128 ESC 2015: Endocarditis
More information2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY
Canadian Nosocomial Infection Surveillance Program 2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY FINAL Working Group: E. Henderson, M. John, I. Davis, S. Dunford,
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationTable 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.
Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationAntibiotic Prophylaxis Update
Antibiotic Prophylaxis Update Choosing Surgical Antimicrobial Prophylaxis Peri-Procedural Administration Surgical Prophylaxis and AMS at Epworth HealthCare Mr Glenn Valoppi Dr Trisha Peel Dr Joseph Doyle
More informationEnterococcal PJI. Miquel Ekkelenkamp
Enterococcal PJI Miquel Ekkelenkamp Enterococci: Gram-positive and round Formerly streptococci (but really quite different) Main clinical species : E. faecalis and E. faecium Mostly opportunistic pathogen
More informationTreatment of PJI. Andrej Trampuz Charité University Medicine Berlin Germany
Treatment of PJI Andrej Trampuz Charité University Medicine Berlin Germany Implants improved life quality Treatment Treatment concept To achieve high treatment success, a concerted surgical and antimicrobial
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationAberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015
Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New
More informationCopyright 2012 Diabetes In Control, Inc. For permission to reprint, please contact Heather Moran, Production Editor, at
Malignant Otitis Externa Inflammation and damage at the base of the skull due to an untreated outer ear P. aeruginosa most common organism Yellow-green drainage from the ear Odor Fever Deep inner ear pain
More informationPrinciples of Antimicrobial Therapy
Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More informationPerichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationCanadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING HIP AND KNEE ARTHROPLASTY
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING HIP AND KNEE ARTHROPLASTY FINAL Working Group: Dominik Mertz (Chair) Elizabeth Henderson, Johan
More informationCUMULATIVE ANTIBIOGRAM
BC Children s Hospital and BC Women s Hospital & Health Centre CUMULATIVE ANTIBIOGRAM 2017 Division of Medical Microbiology Department of Pathology and Laboratory Medicine Page 1 of 5 GRAM-POSITIVE BACTERIA
More informationCanadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS FINAL November 29, 2017 Working Group: Joanne Langley (Chair),
More informationCentral Nervous System Infections
Central Nervous System Infections Meningitis Treatment Bacterial meningitis is a MEDICAL EMERGENCY. ANTIBIOTICS SHOULD BE STARTED AS SOON AS THE POSSIBILITY OF BACTERIAL MENINGITIS BECOMES EVIDENT, IDEALLY
More information2016 Antibiotic Susceptibility Report
Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.
More informationFull Title of Guideline. Author: Contact Name and Job Title. Division & Speciality. Review date December 2020
Full Title of Guideline Author: Contact Name and Job Title Division & Speciality Guideline for the treatment of prosthetic joint infections in adults Mr Peter James - Consultant Orthopaedic Surgeon Dr
More information2015 Antibiotic Susceptibility Report
Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens
More informationTreatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals
Treatment of Surgical Site Infection Meeting Quality Statement 6 Prof Peter Wilson University College London Hospitals TEG Quality Standard 6 Treatment and effective antibiotic prescribing: People with
More informationStaph Cases. Case #1
Staph Cases Lisa Winston University of California, San Francisco San Francisco General Hospital Case #1 A 60 y.o. man with well controlled HIV and DM presents to clinic with ten days of redness and swelling
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationLINEE GUIDA: VALORI E LIMITI
Ferrara 28 novembre 2014 LINEE GUIDA: VALORI E LIMITI Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi EVIDENCE BIASED GERIATRIC MEDICINE Older patients with comorbid conditions
More informationVCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS
VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS CARDIAC Staphylococcus aureus, S. epidermidis, except for For patients with known MRSA colonization, recommend decolonization with Antimicrobial Photodynamic
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationMANAGEMENT OF TOTAL JOINT ARTHROPLASTY INFECTIONS
MANAGEMENT OF TOTAL JOINT ARTHROPLASTY INFECTIONS Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine TOTAL JOINT ARTHROPLASTIES In 2009: 1 million THA and TKA By 2030,
More informationEinheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?
Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how? Andrea Duppenthaler andrea.duppenthaler@insel.ch Limping patient local pain swelling tenderness warmth fever acute Osteomyelitis
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin
ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationGuidelines for the Empirical Treatment of Sepsis in Adults (excluding Neutropenic Sepsis)
Guidelines for the Empirical Treatment of Sepsis in Adults (excluding Neutropenic Sepsis) Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state
More informationThe β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018
The β- Lactam Antibiotics Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018 Penicillins. Cephalosporins. Carbapenems. Monobactams. The β- Lactam Antibiotics 2 3 How
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationDiabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals
Diabetic Foot Infection Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals History of previous amputation [odds ratio (OR)=19.9, P=.01], Peripheral vascular disease (OR=5.5, P=.007)
More informationPIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS
PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS The current supply of piperacillin- tazobactam should be reserved f Microbiology / Infectious Diseases approval and f neutropenic sepsis, severe sepsis
More informationDiagnosis: Presenting signs and Symptoms include:
PERITONITIS TREATMENT PROTOCOL CARI - Caring for Australasians with Renal Impairment - CARI Guidelines complete list ISPD Guidelines: http://www.ispd.org/lang-en/treatmentguidelines/guidelines Objective
More informationCipro for gram positive cocci in urine
Buscar... Cipro for gram positive cocci in urine 20-6-2017 Pneumonia can be generally defined as an infection of the lung parenchyma, in which consolidation of the affected part and a filling of the alveolar
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationSepticaemia Definitions 1
Septicaemia Definitions 1 Term Definition Bacteraemia Systemic Inflammatory response (SIRS) Sepsis Bacteria that can be cultured from the blood stream The systemic response to a wide range of stresses.
More information2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE
ANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE Version 1.0 Date ratified June 2009 Review date June 2011 Ratified by Authors Consultation Nottingham Antibiotic Guidelines Committee
More informationTITLE: NICU Late-Onset Sepsis Antibiotic Practice Guideline
Site: Saint Joseph Hospital - NICU Original Effective Date: 6/1/2016 Next Review Date: 6/1/2019 TITLE: Practice Guideline Purpose: Timely and appropriate treatment of late-onset sepsis with antibiotic
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationProvincial Drugs & Therapeutics Committee Memorandum Version 2
Provincial Drugs & Therapeutics Committee Memorandum Version 2 16 Garfield Street 16, rue Garfield PO Box 2000, Charlottetown C.P. 2000, Charlottetown Prince Edward Island Île-du-Prince-Édouard Canada
More informationHealth PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults
Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults COMMUNITY-ACQUIRED PNEUMONIA HEALTHCARE-ASSOCIATED PNEUMONIA INTRA-ABDOMINAL INFECTION
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationDr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College
Dr. Shaiful Azam Sazzad MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College INTRODUCTION ICU acquired infection account for substantial morbidity, mortality and expense. Infection and
More informationNeurosurgical infections: New developments and outlook
IMPLANTS 28.05.2015 Neurosurgical infections: New developments and outlook Andrej Trampuz, MD Infectious Diseases Specialist Head, Center for Septic Surgery Mª Eugenia Portillo, PhD Microbiologist Head,
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationClinical Practice Standard
Clinical Practice Standard 1-20-6-1-010 TITLE: INTRAVENOUS TO ORAL CONVERSION FOR ANTIMICROBIALS A printed copy of this document may not reflect the current, electronic version on OurNH. APPLICABILITY:
More information10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally
Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationProtocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT
CONTROLLED DOCUMENT Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Guideline Clinical The purpose
More informationAdvanced Practice Education Associates. Antibiotics
Advanced Practice Education Associates Antibiotics Overview Difference between Gram Positive(+), Gram Negative(-) organisms Beta lactam ring, allergies Antimicrobial Spectra of Antibiotic Classes 78 Copyright
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationCellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018
Cellulitis Assoc Prof Mark Thomas Conference for General Practice Auckland Saturday 28 July 2018 Summary Cellulitis Usual treatment flucloxacillin for 5 days Frequent recurrences consider penicillin 250mg
More informationPVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust
PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust Neonatal Case History Neonate born at 26 +2 gestation Spontaneous onset of
More information1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient
1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime
More informationNecrotizing Soft Tissue Infections: Emerging Bacterial Resistance
Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance Eileen M. Bulger, MD Professor of Surgery Harborview Medical Center University of Washington Objectives Review definition & diagnostic
More information* gender factor (male=1, female=0.85)
Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and
More informationINFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER
INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationManagement of CRBSI Leilani Paitoonpong MD MSc Chusana Suankratay MD PhD Division of Infectious Diseases Chulalongkorn University
Management of CRBSI Leilani Paitoonpong MD MSc Chusana Suankratay MD PhD Division of Infectious Diseases Chulalongkorn University A 60-year-old man was admitted for CABG surgery due to triple-vessel disease.
More informationSuper Bugs and Wonder Drugs: Protecting the One While Respecting the Many
Super Bugs and Wonder Drugs: Protecting the One While Respecting the Many Vicki Stringfellow, MSN, CPNP-AC/PC Werner Division of Pediatric Critical Care University of Kentucky Lexington, KY Disclosure
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationOBSTETRICS & GYNAECOLOGY. Penicillin G 5 million units IV ; followed by 2.5 million units 4hourly upto delivery
OBSTETRICS & GYNAECOLOGY A.OBSTETRICS Infection/Condition/likely organism Intrapartum Group B Streptococcal (GBS) infection; positive mothers Suggested treatment Preferred Penicillin G 5 million units
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More information2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital
2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram
More informationInterpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes
Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Prof C. Wattal Hon. Sr. Consultant & Chairman Dept. of Clinical Microbiology Sir Ganga Ram Hospital New Delhi
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationAntimicrobial Prophylaxis in the Surgical Patient. M. J. Osgood
Antimicrobial Prophylaxis in the Surgical Patient M. J. Osgood Outline Definitions surgical site infection (SSI) Risk factors Wound classification Microbiology of SSIs Strategies for prevention of SSIs
More information2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose
2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility
More informationAntibiotics: Selected Topics Steven Park, MD/PhD Director, Antimicrobial Stewardship Program Division of Infectious Diseases UCI Medical Center
Antibiotics: Selected Topics Steven Park, MD/PhD Director, Antimicrobial Stewardship Program Division of Infectious Diseases UCI Medical Center Case 1 60 yo healthy female admitted for fevers and dysuria.
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationScottish Medicines Consortium
Scottish Medicines Consortium daptomycin 350mg powder for concentrate for solution for infusion (Cubicin ) Chiron Corporation Limited No. (248/06) 10 March 2006 The Scottish Medicines Consortium (SMC)
More informationAntibiotic Updates: Part II
Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationTreatment of peritonitis in patients receiving peritoneal dialysis Antibiotic Guidelines. Contents
Treatment of peritonitis in patients receiving Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Jude Allen (Pharmacist) Additional author(s): Dr David Lewis, Dr Dimitrios Poulikakos,
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
PAGE 1 of 3 PURPOSE To assure that DOP inmates with Soft Tissue Infections are receiving high quality Primary Care for their infections and that the risk of infecting other inmates or staff is minimized.
More informationGASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT
GASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT DRAFT AS CURRENTLY OUT FOR CONSULTATION BUT CAN BE UTILISED IN PRESENT FORMAT Name & Title Of Author: Date Revised: Approved by Committee/Group:
More informationnumber Done by Corrected by Doctor Dr.Malik
number 27 Done by Fatimah Farhan Corrected by Basil Al-Bakri Doctor Dr.Malik Note: anything in red is just extra info and you will not be asked about it in the exam. In this sheet we will continue talking
More informationAntibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting
Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria
More informationThe role of oral antibiotics in Prosthetic joint infection. Matthew Dryden MD
The role of oral antibiotics in Prosthetic joint infection Matthew Dryden MD Persistence of bone infection Osteomyelitis in 1930 Prosthetic joint replacement demand is increasing When things go wrong Patient
More information